Imatinib Mesylate

Product NDC
48433-050
11-digit product format
484330050
Labeler code
48433
Product ID
48433-050_4fa8a009-9b1c-3138-e063-6294a90a7320
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
imatinib
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Safecor Health, LLC
Application
ANDA204644
Marketing category
ANDA
Marketing start
2026-04-10
Substance
IMATINIB MESYLATE
Active strength
400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A204644-001IMATINIB MESYLATEIMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21
A204644-002IMATINIB MESYLATEIMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A204644-001AB
A204644-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21d06236e962d9…
2024-10-29 15:01 UTC2024-10A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-211e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-211e350fbaab3a…
2024-05-31 18:47 UTC2024-05A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-218072bd15b7f6…
2024-05-31 18:47 UTC2024-05A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-218072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-215c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-215c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-215d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-215d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-214b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-214b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-2174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-2174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A204644-001IMATINIB MESYLATEEQ 100MG BASETABLET / ORALAB2017-06-21782e0a99824c…
2021-12-28 21:50 UTC2021-12A204644-002IMATINIB MESYLATEEQ 400MG BASETABLET / ORALAB2017-06-21782e0a99824c…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A204644-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A204644-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A204644-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A204644-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A204644-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A204644-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A204644-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A204644-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A204644-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A204644-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A204644-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A204644-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A204644-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A204644-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A204644-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A204644-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A204644-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A204644-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A204644-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A204644-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A204644-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A204644-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A204644-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A204644-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A204644-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A204644-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A204644-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A204644-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A204644-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A204644-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A204644-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A204644-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A204644-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A204644-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A204644-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A204644-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A204644-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A204644-002AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A204644-001AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12A204644-002AB1782e0a99824c…

Additional Listing Data#

Finished product
Yes
Brand name base
Imatinib Mesylate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IMATINIB MESYLATE400 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8A1O1M485BInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
403878Internal RxNorm lookup
403879Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f4acacbd-13f8-4a46-b615-b639a17f331fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2d2ca280-d5c0-49b4-9bbd-0191c7e031beProduct name120250724
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
a07e1ba8-e0e6-1fcb-b05d-47e31d308a05Product name920230314
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
48433-050-01Imatinib Mesylate1 in 1 BLISTER PACKTABLET, FILM COATED12
48433-050-03Imatinib Mesylate30 in 1 CARTONTABLET, FILM COATED302

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Imatinib MesylateIMATINIBGolden State Medical Supply, Inc.9131b2ce-752d-3a30-e053-2a95a90adaab2026-06-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204644
application number: ANDA204644
Imatinib MesylateIMATINIBMylan Pharmaceuticals Inc.a1787fad-3612-43e1-98fa-ce62361e0b3c2026-05-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204644
application number: ANDA204644
Imatinib MesylateIMATINIBSafecor Health, LLCf4acacbd-13f8-4a46-b615-b639a17f331f2026-04-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204644
application number: ANDA204644
ndc (product): 48433-050
Imatinib MesylateIMATINIBMylan Institutional Inc1debf3a0-7587-47d7-8ea6-e739698d72972025-09-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204644
application number: ANDA204644

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
403878imatinib mesylate 100 MG Oral TabletPSNf4acacbd-13f8-4a46-b615-b639a17f331f2
403879imatinib mesylate 400 MG Oral TabletPSNf4acacbd-13f8-4a46-b615-b639a17f331f2
403878imatinib 100 MG Oral TabletSCDf4acacbd-13f8-4a46-b615-b639a17f331f2
403879imatinib 400 MG Oral TabletSCDf4acacbd-13f8-4a46-b615-b639a17f331f2
403878imatinib (as imatinib mesylate) 100 MG Oral TabletSYf4acacbd-13f8-4a46-b615-b639a17f331f2
403879imatinib (as imatinib mesylate) 400 MG Oral TabletSYf4acacbd-13f8-4a46-b615-b639a17f331f2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
48433-050-01484330050011 in 1 BLISTER PACKHistorical
48433-050-034843300500330 BLISTER PACK in 1 CARTON (48433-050-03) / 1 TABLET, FILM COATED in 1 BLISTER PACK (48433-050-01) 30 blister pack2026-04-10NoNoCurrent